Skip to main content

Biopsy Strategies to Detect Small Prostate Cancers

  • Chapter
  • First Online:
Imaging and Focal Therapy of Early Prostate Cancer

Abstract

Early detection of prostate cancer with PSA screening and transrectal ultrasound-guided prostate biopsy has led to stage migration and decreased prostate cancer-related death. Early experience with laterally directed sextant prostate biopsy demonstrated good yield for early prostate cancer detection, but at a cost of missing some smaller cancers. Extended (12–14 cores) prostate biopsies enhanced this yield, and with the development of effective local prostatic nerve block techniques, office-based saturation biopsy techniques with 20 or more cores have become the gold standard for prostate cancer detection in patients with high risk features, although intriguing data on transperineal template-guided mapping biopsy are emerging. Improved detection of small cancers assists the patient and clinician in making treatment decisions, including the decision to embark on active surveillance of a small low grade prostate cancer. In the setting of detecting a small high grade cancer, early detection can potentially improve overall survival rates.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carroll PR. Early stage prostate cancer – do we have a problem with over-detection, overtreatment or both? J Urol. 2005;173(4):1061–2.

    Article  PubMed  Google Scholar 

  2. Hodge KK, McNeal JE, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71–4 (discussion 74–5).

    PubMed  CAS  Google Scholar 

  3. Stamey TA. Making the most out of six systematic sextant biopsies. Urology. 1995;45(1):2–12.

    Article  PubMed  CAS  Google Scholar 

  4. Lui PD, Terris MK, et al. Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol. 1995;153(3 Pt 2):1000–3.

    PubMed  CAS  Google Scholar 

  5. Gore JL, Shariat SF, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001;165(5): 1554–9.

    Article  PubMed  CAS  Google Scholar 

  6. Epstein JI, Walsh PC, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271(5):368–74.

    Article  PubMed  CAS  Google Scholar 

  7. Patel MI, DeConcini DT, et al. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol. 2004;171(4):1520–4.

    Article  PubMed  Google Scholar 

  8. Tosoian JJ, Trock BJ, et al. Active surveillance program for prostate cancer: An update of the johns Hopkins experience. J Clin Oncol. 2011;29(16): 2185–90.

    Article  PubMed  Google Scholar 

  9. Klotz L, Zhang L, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1): 126–31.

    Article  PubMed  Google Scholar 

  10. Tan N, Lane BR, et al. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. J Urol. 2008;180(4):1325–9 (discussion 1329).

    Article  PubMed  Google Scholar 

  11. Berglund RK, Masterson TA, et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol. 2008;180(5):1964–7 (discussion 1967–8).

    Article  PubMed  Google Scholar 

  12. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151(6): 1571–4.

    PubMed  CAS  Google Scholar 

  13. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol. 2002;167(6):2435–9.

    Article  PubMed  Google Scholar 

  14. Borboroglu PG, Comer SW, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol. 2000;163(1):158–62.

    Article  PubMed  CAS  Google Scholar 

  15. Soloway MS, Obek C. Periprostatic local anesthesia before ultrasound guided prostate biopsy. J Urol. 2000;163(1):172–3.

    Article  PubMed  CAS  Google Scholar 

  16. Jones JS, Ulchaker JC, et al. Periprostatic local anesthesia eliminates pain of office-based transrectal prostate biopsy. Prostate Cancer Prostatic Dis. 2003;6(1): 53–5.

    Article  PubMed  CAS  Google Scholar 

  17. Patel AR, Jones JS, et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology. 2004;63(1):87–9.

    Article  PubMed  Google Scholar 

  18. Ching CB, Zaytoun O, Moussa AS, Li J, Avallone A, Jones JS. Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy. BJU Int. 2012;110(2 Pt B):E46–9.

    Article  PubMed  Google Scholar 

  19. Ching CB, Moussa AS, et al. Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates. J Urol. 2009;181(5):2077–82 (discussion 2082–3).

    Article  PubMed  Google Scholar 

  20. Zaytoun OM, Moussa AS, et al. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. J Urol. 2011;186(3):850–4.

    Article  PubMed  Google Scholar 

  21. Abouassaly R, Lane BR, Jones JS. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology. 2008;71(4):573–7.

    Article  PubMed  Google Scholar 

  22. Emiliozzi P, Corsetti A, et al. Best approach for prostate cancer detection: A prospective study on transperineal versus transrectal six-core prostate biopsy. Urology. 2003;61(5):961–6.

    Article  PubMed  CAS  Google Scholar 

  23. Watanabe M, Hayashi T, et al. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol. 2005;12(11):959–63.

    Article  PubMed  Google Scholar 

  24. Abdollah F, Novara G, et al. Trans-rectal versus trans-perineal saturation rebiopsy of the prostate: Is there a difference in cancer detection rate? Urology. 2011;77(4):921–5.

    Article  PubMed  Google Scholar 

  25. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate–a 4-year experience. Urology. 2007;70(6 Suppl):27–35.

    Article  PubMed  Google Scholar 

  26. Onik G, Miessau M, Bostwick DG. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol. 2009;27(26):4321–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryan Berglund M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Berglund, R., Jones, J.S. (2013). Biopsy Strategies to Detect Small Prostate Cancers. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-182-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-182-0_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-181-3

  • Online ISBN: 978-1-62703-182-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics